Skip to content

Randomized controlled clinical study on the efficacy and safety of Ciprofol injection in strabismus correction

Randomized controlled clinical study on the efficacy and safety of Ciprofol injection in strabismus correction

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053430
Enrollment
Unknown
Registered
2021-11-21
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismus

Interventions

Ciprofol group:Intravenous injection of Ciprofol 0.3mg/kg
Propofol group:Intravenous injection of Propofol 1.5mg/kg

Sponsors

the Affiliated Hospital of Yunnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. 18-45 years old, gender is not limited; 2. American Anesthesiologist Classification (ASA) I-II; 3. Patients who need MAC for elective strabismus surgery; 4. Body mass index (BMI) >=18 and =10 and =95% when breathing air; systolic blood pressure (SBP) >=90mmHg and =60mmHg and =55 and <=100 beats/min; 6. Be able to understand the research process and methods, and voluntarily participate in this research.

Exclusion criteria

Exclusion criteria: 1. Those with contraindications to intravenous general anesthesia or those who have had a history of anesthesia accident in the past; 2. Known or suspected to be allergic or contraindicated to propofol injection, cyclopofol injection and other excipients; 3. Combined with craniocerebral loss, intracranial hypertension, stroke, unstable angina, myocardial infarction; 4. Respiratory insufficiency, obstructive pulmonary disease, having a difficult airway, or being judged to have difficulty in endotracheal intubation (modified Markov score grade III or IV) 5. Severe liver dysfunction or severe renal insufficiency; 6. History of alcoholism or drug dependence; 7. Abuse or long-term use of narcotic, sedative, and analgesic drugs; 8. Those who have a history of mental illness in the past; 9. Those who have participated in any drug clinical trials within 1 month before screening; 10. Pregnant and lactating women; fertile women or men who are unwilling to use contraception throughout the trial period; subjects (including male subjects) who have a pregnancy plan within 1 month after the trial; 11. Subjects who are considered by the investigator to have any other factors that are not suitable for participating in this trial.

Design outcomes

Primary

MeasureTime frame
Success rate of anesthesia induction;

Countries

China

Contacts

Public ContactSu Guoning

the Affiliated Hospital of Yunnan University

suguoning18@163.com+86 18687107829

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026